The use of liposomal amphotericin B in the treatment of neutropenia-associated fungal infections: efficacy and cost-effectiveness.
Newland
A C
AC
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D008081:Liposomes; D009181:Mycoses / Q000188:drug therapy*; D009503:Neutropenia / Q000150:complications*
D000935:Antifungal Agents; D008081:Liposomes; D000666:Amphotericin B